ArticleDiscover oncology2026

Pan-cancer analysis identifies APOC1 as a TAM-derived modulator of adaptive immune resistance and predictor of therapeutic response.

Yang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.